comparemela.com

Latest Breaking News On - 9mfy23 - Page 1 : comparemela.com

Ecom Express: Ecom Express posts 20% rise in FY23 revenue to Rs 2,548 crore, loss widens

Ecom Express s FY23 revenue rose 20% to Rs 2,548 crore, but with a widened loss at Rs 375 crore due to increased total expenses. Courier services revenue exceeded Rs 2,300 crore.

Delhi
India
Ajay-chitkara
Bharti-airtel
Indian-school-of-business
Technology-leadership
Registrar-of-companies
Offering-college
Certificate-programme-in-data-science-machine
Ecom-express
Tech-prowess
High-value-skill

Lenskart FY23: Lenskart revenue jumps to Rs 3,788 crore in FY23; trims losses to Rs 102 crore

On a standalone basis, Lenskart has been profitable, and reported a net profit of Rs 138 crore in FY23, a 25-fold jump from the previous fiscal. Standalone operating revenue stood at Rs 2,375 crore.

India
Philippines
Kozhikode
Kerala
Abu-dhabi
Abuz-aby
United-arab-emirates
Thailand
Singapore
Paris
France-general
France

Business News: 4 labour codes likely to be implemented by FY23 as many states ready draft rules

4 labour codes likely to be implemented by FY23 as many states ready draft rules : Rashtra News The four labour codes on wages, social security, industrial relations and occupation safety, health and working conditions are likely to be implemented by the next fiscal year as at least 13 states have pre-published draft rules on

Haryana
India
Puducherry
Pondicherry
Madhya-pradesh
Karnataka
Delhi
Telangana
Andhra-pradesh
Tripura
Odisha
Orissa

Balaxi Pharmaceuticals Reports Continued Solid Growth in Q1 FY23

Hyderabad, Telangana, India Revenue grows 42% in Q1FY23. ​Pharma Revenue in Latin America up 39%. Profit After Tax up 32% YoY. Balaxi Pharmaceuticals Limited (Balaxi), a branded IPR-based pharmaceutical company headquartered in Hyderabad, reported its results for the first quarter of financial year

Angola
Telangana
Andhra-pradesh
India
Dominican-republic
Portugal
United-states
Hyderabad
Guatemala
China
American
America

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.